PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1188
Publisher
MDPI AG
Online
2020-05-08
DOI
10.3390/cancers12051188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tracking cancer progression: from circulating tumor cells to metastasis
- (2020) Francesc Castro-Giner et al. Genome Medicine
- “Circulating Tumor Cells: Finding Rare Events for a Huge Knowledge of Cancer Dissemination”
- (2020) Catherine Alix-Panabières Cells
- Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
- (2019) Klaus Pantel et al. CLINICAL CHEMISTRY
- Liquid biopsy and minimal residual disease — latest advances and implications for cure
- (2019) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- PIM kinase inhibitors: Structural and pharmacological perspectives
- (2019) Vivek Asati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prostate cancer screening: guidelines review and laboratory issues
- (2019) Xavier Filella et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
- (2019) Eleni Tzanikou et al. Molecular Oncology
- Evolution of the Liquid Biopsy in Metastatic Prostate Cancer
- (2019) Jose G. Moreno et al. UROLOGY
- Gene Expression Alterations during Development of Castration-Resistant Prostate Cancer Are Detected in Circulating Tumor Cells
- (2019) Andreas Josefsson et al. Cancers
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In Situ Detection and Quantification of AR-V7, AR-FL, PSA, andKRASPoint Mutations in Circulating Tumor Cells
- (2018) Amin El-Heliebi et al. CLINICAL CHEMISTRY
- Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies
- (2018) Martha Zavridou et al. CLINICAL CHEMISTRY
- Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
- (2018) Howard I. Scher et al. JAMA Oncology
- Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress
- (2018) Changwen Zhang et al. CARCINOGENESIS
- Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
- (2018) Mitchell G. Lawrence et al. EUROPEAN UROLOGY
- Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities
- (2017) Khaled A.M. Abouzid et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of new pyridothienopyrimidinone and pyridothienotriazolopyrimidine derivatives as pim-1 inhibitors
- (2017) Hala B. El-Nassan et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Analysis of DNA methylation in single circulating tumor cells
- (2017) C F Pixberg et al. ONCOGENE
- Treatment of Advanced Prostate Cancer—A Review of Current Therapies and Future Promise
- (2017) Semini Sumanasuriya et al. Cold Spring Harbor Perspectives in Medicine
- Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors
- (2016) Kun Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors
- (2016) Yin-Bo Fan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions
- (2016) R J Hendriks et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors
- (2015) Ryan P. Wurz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PIM kinase (and Akt) biology and signaling in tumors
- (2015) Noel A. Warfel et al. PHARMACOLOGY & THERAPEUTICS
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition
- (2014) Virginie Suchaud et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
- (2014) A. Markou et al. CLINICAL CANCER RESEARCH
- PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance
- (2014) Sheldon Holder et al. CURRENT CANCER DRUG TARGETS
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases
- (2013) Francesco Casuscelli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1
- (2013) B. Cen et al. CANCER RESEARCH
- Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer
- (2013) Terence W. Friedlander et al. INTERNATIONAL JOURNAL OF CANCER
- The PIM Family of Serine/Threonine Kinases in Cancer
- (2013) Maja Narlik-Grassow et al. MEDICINAL RESEARCH REVIEWS
- SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
- (2012) M. Chimonidou et al. CLINICAL CHEMISTRY
- Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases
- (2011) Gisele A. Nishiguchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Why target PIM1 for cancer diagnosis and treatment?
- (2010) Nancy S Magnuson et al. Future Oncology
- Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
- (2010) J Wang et al. ONCOGENE
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
- (2009) Howard I Scher et al. LANCET ONCOLOGY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started